SUMMARY
INTRODUCTION
Microsporidia spp. are obligate intracellular eukaryotic parasites which form small oval spores (1) . Although there are about 1200 species of Microsporidia sp. which can infect both vertebrate and nonvertebrated hosts, most of the human microsporidiosis infections are caused by Enterocytozoon sp. and Encephalitozoon spp. (1, 2) . In recent studies using genetic analyses, the zoonotic potential has clearly been documented about these parasites (3) .
The clinical course of microsporidiosis varies with the site of the infection and the host immunity. Asymptomatic or moderate microsporidiosis is likely to remain a local infection in immunocompetent people, while it may present with infections of the hepatobiliary, pulmonary, renal and central nervous systems in addition to severe diarrhea in patients with AIDS and those with iatrogenic immunodeficiency (2, 4) .
It has been shown that Microsporidia spp. can infect the respiratory tract and the lungs (5). Furthermore, there has an increase in the number of reports on pulmonary microsporidiosis in recent years (6) . Pulmonary colonization resulting from contamination through inhalation and regurgitation or oral-fecal and hematogenous routes can lead to opportunistic infections presenting with fever, cough and dyspnea especially in patients with AIDS and transplant recipients (2, (5) (6) (7) (8) . There have also been reports showing that the parasite can be detected in specimens from the respiratory tract in patients with urinary and intestinal microsporidiosis (6, 10) . Botterel et al. detected Microsporidia spores in BAL specimens from an AIDS patient with intestinal microsporidiosis and they concluded that the patient had an asymptomatic colonization since he did not have any pulmonary complaints (6).
In Turkey, it has been observed that both clinicians and laboratory specialists do not take account of microsporidiosis in the differential diagnosis of pulmonary infections. Prior studies on this issue mostly focus on revealing intestinal microsporidiosis and a range of 1.05-69.9% Microsporidia spp. positivities in different patient groups have been reported (11) (12) (13) (14) (15) (16) (17) (18) (19) . However there have not been any studies on the prevalence of pulmonary microsporidiosis in our country. Therefore, in this study we aimed to investigate the pulmonary microsporidiosis in iatrogenically immunosuppressed patients.
MATERIALS and METHODS

Patients
BAL specimens sent to Parasitology Laboratory of Dokuz Eylül University Hospital between January 2011 and May 2014 were examined in this study. Sixty-three iatrogenically immunosuppressed patients developing pulmonary infection while being followed in hematology-oncology, bone marrow transplantation, 
BAL Specimens and DNA Extraction
BAL specimens were centrifuged at 1500 rpm for 10 min and 200 μL of obtained pellet was kept at -20°C until DNA extraction. DNA extraction was performed with an extraction kit (Macherey-Nagel, Düren, Germany) in accordance with the manufacturer's guidelines. Ultrapure distilled water was used as negative control and Enterocytozom cuniculi isolate obtained from ATCC isolate bank (founded in the framework of a project conducted by TUBITAK) was used as positive control.
Microsporidia PCR
Small-subunit ribosomal DNA (SSU-rDNA) regions at 250-279 bp were amplified with the primers PMP1 (5'-CACCAGGTTGATTCTGCCTGAC-3') and PMP2 (5'-CCT CTCCGGAACCAAACCCTG-3') specifically designed for Enterocytozoon bieneusi, Encephalitozoon intestinalis, E. cuniculi and Encephalitozoon hellem (14, 18, (20) (21) . For each reaction, 2.5 μL 10x reaction buffer, 2.5 μL MgCl 2 (25 mM stock solution), 2.5 μL dNTP (2 mM stock solution), 1 μL Hot start Taq DNA polymerase (1 U/μL stock solution), 0.75 μL primer (10 μM stock solution) and 5 μL DNA sample were added and the final volume was completed to 25 μL with distilled water. Amplification was performed under the following conditions: after an initial denaturation at 94°C for 10 minutes, 35 cycles at 94°C for 30 seconds, at 60°C for 30 seconds, at 72°C for 30 seconds and final extension at 72°C for 10 minutes (20, 21) . In order to enhance sensitivity, a 5-μL specimen taken from the first amplification product was amplified again with the same primers under the same conditions as in the first reaction (20, 21) . To evaluate amplification of target DNA, 10 μL-amplification products were analysed by electrophoresis on 1.5% agarose gel under 100 volt for one hour. Then gel was stained with 1 μg/mL ethidium bromide and visualized under UV light. PCR was repeated three times for each specimen, for confirmation of results.
Staining
PCR positive BAL specimens were subjected to staining with Weber's modified trichrome after cytocentrifugation and examined under light microscopy at a final magnification of (x) 1000 (14) .
Statistical Analysis
Statistical analyses were made with SPSS 15.0. Chisquare test was used for assessing the difference in prevalences. Mann-Whitney U test and Fisher's exact test were used to compare differences between the patients with Microsporidia spp. and those without Microsporidia spp. in the study group. p< 0.05 was considered significant.
RESULTS
In the study group, there were 45 males (71%) and 18 females (29%) with a median age of 58 years (18-71 years). In the control group, there were 19 males (68%) and nine females (32%) with a median age of 63 years (27-66 years). Of 63 patients with iatrogenic immunosuppression, 38 were on anticancer treatment, 14 were on corticosteroid treatment (> 20 mg/day), eight were on anti-rejection treatment (azathioprine, cyclosporine, mycophenolate mofetil etc.) and three were taking other immunosuppressants (methotrexate, TNF-α inhibitors). Microsporidia PCR positivities were detected in nine out of 63 immunosuppressed patients (14.2%), there was no positivity in immunocompetent patients (Figure 1 ). The prevalence of Microsporidia spp. was statistically higher in the immunosuppressed patients (χ² = 4.439; p= 0.035).
The median age was higher in PCR positive immunosuppressed patients (median age: 66 years; range: 35-78 years) than in those with PCR negative (median age: 57 years; range: 18-89 years), though the difference was not significant (p= 0.06) ( Table 1) . There was not a significant difference between PCR positivity and gender (p= 0.255). Characteristics of study and control groups are shown in Table 1 .
Cytological investigation of the PCR positive BAL specimens revealed microsporidian spores only in one patient (Figure 2 ). This patient with multiple myeloma had no other microbial pathogens. Laboratory results Table 2 .
DISCUSSION
It is known that Microsporidia spp. cause severe systemic infections in immunosuppressed patients but there is little epidemiological evidence for pulmonary microsporidiosis. It is thought that many possible infections might be overlooked due to not only insufficient focus on microsporidiosis in the differential diagnosis of infections but also difficulties in detection of Microsporidia spp. in laboratory investigations (1) (2) (3) (4) .
Most reports about pulmonary microsporidiosis have been stated as case reports in immunosuppressed patients. It is generally observed in patients with AIDS and transplant recipients, may vary from asymptomatic colonization to death from cardiopulmonary failure (7) (8) (9) (10) (22) (23) (24) (25) (26) . On the other hand there has been only one study on the prevalence of pulmonary microsporidiosis. Lobo et al. investigated presence of Microsporidia spp. in BAL specimens from 150 HIV patients and 50 non-HIV patients with PCR in Portugal (27) . Although there was no positivity in non-HIV patients, they reported that two HIV patients had Microsporidia spp. So far, only one article has been published in our country about pulmonary microsiporidiasis. Yazar et al. reported that a myeloblastic leukemia (AML-M3) patient presenting with fever, cough, dyspnea and sputum had microsporidian spores in BAL specimens (26) . In this study, for the first time, the prevalence of pulmonary microsporidiosis was investigated in Turkey. As far as we know it is the first report which conducted in immunosuppressed patients without HIV. The results showed that 14.2% of the iatrogenically immunosuppressed patients had pulmonary microsporidiosis.
When the literature data about microsporidiosis prevalence analyzed, it was found that researches in our country had mostly dealed with intestinal microsporidiosis. Intestinal microsporidiosis prevalence have been reported between 1.05-69.9 % in patients with different immune status from different geographic regions (11) (12) (13) (14) (15) (16) (17) (18) (19) . The results of these studies show that we often come acroos this zoonotic pathogen. This situation may be one of the reasons of high pulmonary microsporidiosis prevalence that we found in our study.
Pulmonary microsporidiosis has been thought to be due to dissemination of gastrointestinal or urinary tract infections rather than an external transmission (1,2,6). Initiation of pulmonary symptoms following diarrhea due to E. bieneusi in patients with AIDS and isolation of the same causative agent in the patients' pulmonary specimens contributes to the above mentioned view (1, 22) . This study was directed towards detection of E. cuniculi, E. bieneusi, E. hellem and E. intestinalis, most frequently isolated species in human infections. By using common primers, SSUrDNA gene of the parasites were amplified. Unfortunately, since genotyping could not be performed to confirm the types of species, all PCR positive specimens were considered as having Microsporidia spp. in general. However since this is a retrospective study, urine and feces specimens from the patients with Microsporidia PCR positivity could not be accessed and could not be evaluated for Microsporidia spp.
The symptoms fever, cough, wheezing, dyspnea and imaging signs such as lobar consolidation are not specific for clinical diagnosis of microsporidiosis (1, (5) (6) (7) (8) (9) (10) 22) . Researchers had to make their decisions regarding the other pathogens found in BAL specimens. Scaglia et al. reported two AIDS patients having pulmonary symptoms and E. hellem in their BAL specimens. One of these patient was evaluated as Pneumocystis carinii pneumonia (PCP) and the other as tuberculosis. Therefore, the presence of E. hellem was concluded as colonization (9 Microsporidia PCR positive patients were also included in another study about P. jirovecii colonization and nested PCR revealed P. jirovecii DNA (unpublished data). Since they haven't received anti-PCP treatment, their responses to treatment could not be evaluated. It remained unclear whether the patients had PCP or P. jirovecii colonization. As a result, it could not be revealed whether the symptoms were due to microsporidiosis and/or PCP. However, one of the PCR positive patients had Microsporidia spores in BAL specimen. Examination of BAL sediment was negative for P. jirovecii and other microbiological pathogens. He had nonspecific symptoms such as fever, cough and respiratory distress. On physical examination, there were widespread crepitan ralles in both lungs and in radiographic examinations, diffuse, bilateral pulmonary oposities and extensive consolidations areas were determined. The patient did not respond to empirical treatments and died. Pulmonary symptoms in this patient might be caused by Microsporidia spp. The last Microsporidia PCR positive patient who did not have any other microbiological agents in BAL specimen did not receive specific treatments for microsporidiosis. The patient recovered as a result of empirical and supportive treatment and was discharged. Therefore, it was considered as Microsporidia spp. colonization.
CONCLUSION
The present study is the first to investigate the prevalence of pulmonary microsporidiosis in immunosuppressed patients in Turkey. The results of the study showed that Microsporidia spp. should be taken into consideration in the differential diagnosis of pulmonary infections in iatrogenically immunosuppressed patients and the diagnosis by conventional staining is inadequate and should be supported by molecular methods.
